![](https://webarchive.library.unt.edu/eot2008/20081102033411im_/http://www.nci.nih.gov/images/spacer.gif) |
|
(… suh-LOO-shun)
![](https://webarchive.library.unt.edu/eot2008/20081102033411im_/http://www.nci.nih.gov/images/spacer.gif)
| A form of biological therapy for superficial (not invasive) bladder cancer. The solution is made from a weakened form of the bacterium Mycobacterium bovis (bacillus Calmette-Guérin) that does not cause disease but stimulates the body’s immune system. A catheter is used to place the BCG solution into the bladder where it is held for about two hours. |
Previous Definitions: | BBBD, BBIC, BBR 2778, BBR 3464, BCG | Next Definitions: | bcl-2 antisense oligodeoxynucleotide G3139, BCL2, BCR-ABL fusion gene, BCX-1777, BDC |
|
![](https://webarchive.library.unt.edu/eot2008/20081102033411im_/http://www.nci.nih.gov/images/spacer.gif) |